跳至主要内容
临床试验/DRKS00033794
DRKS00033794招募中不适用

Treatment patterns and survival of individuals with early stage non-small cell lung cancer in Germany - a study based on cancer registry data (I-O OPTIMISE / VONKO-019) - VONKOdb Early stage NSCLC 2023

Bristol Myers Squibb0 个研究点目标入组 70,000 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
70,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 120 Years(—)
性别
All

入选标准

  • diagnosis years 2016-2019
  • - place of residence in respective federal state of cancer registry

排除标准

  • patient is known to the cancer registry only by means of death certificate, a pathology report, a follow up notification, a tumor conference report or a combination of the aforementioned

研究者

发起方
Bristol Myers Squibb

相似试验